Cocaine- and amphetamine-regulated transcript peptide-(55–102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release
Luigi Brunetti(University of Chieti-Pescara), Michèle Vacca(University of Cambridge), Barbara Michelotto(University of Chieti-Pescara), Lucia Recinella(University of Chieti-Pescara), Giustino Orlando(University of Chieti-Pescara)
Cited by 41
Related Papers
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases
|Frontiers in Physiology|2020|264
Crocus sativus L. stigmas and byproducts: Qualitative fingerprint, antioxidant potentials and enzyme inhibitory activities
|Food Research International|2018|142
Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus
|European Journal of Pharmacology|2002|120
Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
|International Journal of Molecular Sciences|2020|110